Current Report Filing (8-k)
27 3월 2023 - 7:02PM
Edgar (US Regulatory)
0001419051
false
0001419051
2023-03-24
2023-03-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): March 24, 2023
THERAPEUTIC
SOLUTIONS INTERNATIONAL, INC. |
(Exact
Name of Registrant as Specified in its Charter) |
Nevada |
|
000-54554 |
|
45-1226465 |
(State
or other jurisdiction of
incorporation
or organization) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
Number) |
701
Wild Rose Lane |
Elk
City, Idaho 83525 |
(Address
of Principal Executive Offices and Zip Code) |
|
(760)
295-7208 |
(Issuer’s
telephone number) |
|
|
(Former
Name or Former Address, if Changed Since Last Report) |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item
8.01 Other Events – Letter to Shareholders and Interested Parties.
To
All Shareholders and Interested Parties,
On
or about March 21, 2023, the Board of Directors of Therapeutic Solutions International, Inc. (“TSOI”), by unanimous approval,
and with the unanimous approval of the Preferred A Stock holders representing at least 51% of all shareholders with the right to vote,
pursuant to Nevada Revised Statutes Section NRS 78.215, has approved a one-time dividend, to be awarded to stockholders of TSOI in subsidiary
Campbell Neurosciences, Inc., a Delaware corporation (“CNSI”). To receive the dividend by future election you must hold TSOI
common at the market close of April 7, 2023. The dividend rate of conversion shall be for every share of TSOI common you will receive
0.0034 shares of CNSI.
TSOI,
which owns 15,660,000 (31%) of the shares of CNSI common stock, would like to issue a dividend consisting of 10,000,000 shares of its
holdings in CNSI to TSOI shareholders at a ratio of 0.00365 shares of CNSI stock for each one (1) share owned in TSOI stock as of April
7, 2023 (“Dividend Offer”) on April 8, 2023 (“Dividend Offer Date”). The Dividend Offer will remain open for
Ninety (90) days from the Dividend Offer Date.
A
letter will be mailed to every shareholder of record details of how to accept the Dividend Offer and a fully pre-paid return acceptance
letter containing the necessary information for issuance. In addition, a Shareholder’s Rights Agreement will be enclosed, an executed
copy to be returned with acceptance.
Required
forms and documents shall be filed with FINRA describing the identity of the parties and the Dividend Offer timely.
Item
9.01 Financial Statements and Exhibits.
Exhibit
Index
(99.1)
TSOI Board Minutes
(99.2)
CNSI Board Minutes
(99.3)
TSOI_Div Offer Ltr and Accept form_final
(99.4) Shareholder_Rights_Agt Form-Campbell Dividend Offer_final
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
March 24, 2023
THERAPEUTIC
SOLUTIONS INTERNATIONAL, INC.
By: |
/s/
Timothy Dixon |
|
By: |
/s/
Thomas Ichim |
|
Timothy
Dixon |
|
|
Thomas
Ichim |
|
Chief
Executive Officer, Director |
|
|
Director |
Therapeutic Solutions (PK) (USOTC:TSOI)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Therapeutic Solutions (PK) (USOTC:TSOI)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
Therapeutic Solutions International Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Therapeutic Solutions International, Inc. News Articles